Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyltransferase 6 (GGT6) is a membrane-bound extracellular enzyme in the gamma-glutamyltransferase family that catalyzes the transfer of the γ-glutamyl group from glutathione and other peptides to acceptor amino acids or peptides. This enzymatic process is critical for maintaining glutathione homeostasis, and thus contributes to antioxidant defense, detoxification, and amino acid transport. GGT6 is expressed in various tissues, though its specific biological role appears context-dependent, and genetic studies suggest alterations in its function may influence the risk of inflammatory diseases such as rheumatoid arthritis.
Hydrolyzes and transfers gamma-glutamyl moieties from glutathione and related compounds to acceptor molecules, influencing cellular redox status
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-glutamyltransferase 6 (GGT6).